American Society of Hematology articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/11/27 20:36
2014/11/27 20:36
1h
UNDATED (AP) Scientists have discovered a gene mutation among older people that could start them on the path to leukemia, lymphoma or other blood disease, The discovery of the so-called "pre-cancer"...
2014/11/27 20:36
2014/11/27 20:36
Latest videos
2014/11/27 01:28
2014/11/27 01:28
20h
Researchers discover 'pre-cancers' in blood UNDATED (AP) — Scientists have discovered a gene mutation among older people that could start them on the path to leukemia, lymphoma or other blood...
2014/11/14 09:08
2014/11/14 09:08
13d
Cornerstone Pharmaceuticals, Inc., a development stage company and leader in the growing field of cancer metabolism-based therapeutics, today announced that its lead compound CPI-613 has been chosen...
2014/11/12 09:17
2014/11/12 09:17
15d
LAUSANNE, Switzerland--(BUSINESS WIRE)--Oncoethix, the Swiss-based specialist in oncology drug development, today announced that the first patient has been enrolled in an international, open-label,...
2014/11/12 09:17
2014/11/12 09:17
15d
LAUSANNE, Schweiz--(BUSINESS WIRE)--Oncoethix, ein auf die Entwicklung onkologischer Arzneimittel spezialisiertes Unternehmen mit Sitz in der Schweiz, gab heute bekannt, dass die ersten Patienten für...
2014/11/07 18:08
2014/11/07 18:08
20d
Interim data from an ongoing Phase I/II trial of Actimab-A, an innovative targeted payload immunotherapy, demonstrated a number of positive findings, including extension of overall survival and...
2014/11/07 12:17
2014/11/07 12:17
20d
BOSTON--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that a paper, titled...
2014/11/07 07:18
2014/11/07 07:18
20d
ERYTECH (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology...
2014/11/06 23:17
2014/11/06 23:17
20d
CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502) today announced that abstracts of interest from studies on VELCADE® (bortezomib), ADCETRIS®...
2014/11/06 21:17
2014/11/06 21:17
21d
CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that researchers will present data from clinical studies of Soliris® (eculizumab) in patients with...
2014/11/06 16:22
2014/11/06 16:22
21d
New Patient Receiving BlueBird Gene Therapy Responding More Slowly CAMBRIDGE, Mass. ( TheStreet) -- BlueBird Bio(BLUE) shares surged higher in June on excitement over stellar responses in two...
2014/11/06 14:17
2014/11/06 14:17
21d
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that in November and December, data will be presented for the first time...
2014/11/27 20:36
2014/11/27 20:36
Latest from Twitter